![Matthew Outten](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Matthew Outten
Corporate Officer/Principal bij
BRIDGEBIO PHARMA, INC.
Profiel
Matthew Outten is currently the Chief Commercial Officer at QED Therapeutics, Inc. and also holds the position of Chief Commercial Officer at BridgeBio Pharma, Inc. He previously worked as the Vice President-Marketing & Marketing Access at Pharmacyclics LLC from 2013 to 2018.
Outten completed his undergraduate degree at Hamilton College (New York) and earned an MBA from the University of Delaware.
Actieve functies van Matthew Outten
| Bedrijven | Functie | Begin |
|---|---|---|
| BRIDGEBIO PHARMA, INC. | Corporate Officer/Principal | 01-02-2019 |
QED Therapeutics, Inc.
 QED Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals | Corporate Officer/Principal | - |
Eerdere bekende functies van Matthew Outten
| Bedrijven | Functie | Einde |
|---|---|---|
| PHARMACYCLICS, INC. | Corporate Officer/Principal | - |
Opleiding van Matthew Outten
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
25
Eerstegraads connecties
5
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Pharmacyclics LLC
 Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Manufactures drugs intended to treat cancer and atherosclerosis | Health Technology |
Hamilton College (New York)
 Hamilton College (New York) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Delaware
 University of Delaware Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
QED Therapeutics, Inc.
QED Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals | Health Technology |
BridgeBio Pharma, Inc.
 BridgeBio Pharma, Inc. BiotechnologyHealth Technology Develops medicines for genetic diseases to patients | Health Technology |
